Effects of tissue plasminogen activator on cerebral microvessels of rats during focal cerebral ischemia and reperfusion

REFERENCES

• Fieschi C, Argentino GL, Lenzi ML, et al. Clinical and instrumental evaluation of patients with ischemic stroke within the first six hours. J Neurol Sci 1989; 91: 311–322
   PubMed Web of Science ®Google Scholar
• Siesjö BK. Mechanisms of ischemic brain damage. Crit Care Med 1988; 16: 954–963
   PubMed Web of Science ®Google Scholar
• Thrombolytic therapy with streptokinase in acute ischemic stroke. The Multicenter Acute Stroke Trial—Europe Study Group. N Engl J Med 1996; 335: 145–150
   PubMed Web of Science ®Google Scholar
• controlled trial of streptokinase, aspirin and combination of both in treatment of acute ischaemic stroke. Multicenter Acute Stroke Trial—Italy (MAST-I) Group. Lancet 1995; 346: 1509–1514
   PubMed Web of Science ®Google Scholar
• Gonner F, Remonda L, Mattle H, et al. Local intra-arterial thrombolysis in acute ischemic stroke. Stroke 1998; 29: 1894–1900
   PubMed Web of Science ®Google Scholar
• Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Study Group. N Engl I Med 1995; 333: 1581–1587
   PubMed Web of Science ®Google Scholar
• Ueda T, Hatakeyama T, Kumon Y, et a/. Evaluation of risk of hemorrhagic transformation in local intra-arterial thrombolysis in acute ischemic stroke by initial SPECT. Stroke 1994; 25: 298–303
   PubMed Web of Science ®Google Scholar
• Tsuji K, Aoki T, Tejima F, et al. Tissue plasminogen activator promotes matrix met alloproteinase-9 upregulation after focal cerebral ischemia. Stroke 2005; 36: 1954–1959
   PubMed Web of Science ®Google Scholar
• Gulba DC, Bode C, Runge MS, et al. Thrombolytic agents—an overview. Ann Hematol 1996; 73: S9—S27
   PubMed Web of Science ®Google Scholar
• Werner RG, Bassarab S, Hoffman H, et al. Quality aspects of fibrinolytic agents based on biochemical characterization. Drug Res 1991; 41: 1196–1200
   Web of Science ®Google Scholar
• Kano T, Katayama Y, Tejima E, et al. Hemorrhagic transformation after fibrinolytic therapy with tissue plasminogen activator in a rat thromboembolic model of stroke. Brain Res 2000; 854: 245–248
   PubMed Web of Science ®Google Scholar
• Fagan SC, Garcia JH. Hemorrhagic transformation in focal cerebral ischemia: Influence of time-to-artery reopening and tissue plasmi-nogen activator. Pharmacotherapy 1999; 189: 139–142
   Google Scholar
• Chen ZL, Indyk JA, Strickland S. The hippocampal laminin matrix is dynamic and critical for neuronal survival. Mol Biol Cell 2003; 14: 2665–2676
   PubMed Web of Science ®Google Scholar
• Hamann GF, Okada Y, Fitridge R, et al. Microvascular basal lamina antigens disappear during cerebral ischemia and reperfu-sion. Stroke 1995; 26: 2120–2126
   PubMed Web of Science ®Google Scholar
• Hamann GF, Okada Y, del Zoppo GJ. Hemorrhagic transformation and microvascular integrity during focal cerebral ischemia/ reperfusion. I Cereb Blood Flow Metab 1996; 16: 1373–1378
   PubMed Web of Science ®Google Scholar
• Hamann GF, Liebetrau M, Martens H, et al. Microvascular basal lamina injury after experimental focal cerebral ischemia and reperfusion in the rat. I Cereb Blood Flow Metab 2002; 22: 526–533
   PubMed Web of Science ®Google Scholar
• Yepes M, Sandkvist M, Wong MK, et al. Neuroserpin reduces cerebral infarct volume and protects neurons from ischemia-induced apotosis. Blood 2000; 96: 569–576
   PubMed Web of Science ®Google Scholar
• Zhang ZG, Zhang L, Tsang W, et al. Dynamic platelet accumula-tion at the site of the occluded middle cerebral artery and in downstream microvessels is associated with loss of microvascular integrity after embolic middle cerebral artery occlusion. Brain Res 2001; 912: 181–194
   PubMed Web of Science ®Google Scholar
• Horstmann S, Kalb P, Koziol J, et al. Profiles of matrix met al loproteinases, their inhibitors, and laminin in stroke patients: Influence of different therapies. Stroke 2003; 34: 2165–2170
   PubMed Web of Science ®Google Scholar
• Rosenberg GA, Navratil M, Barone F, et al. Proteolytic cascade enzyme increase in focal cerebral ischemia in rats. I Cereb Blood Flow Metab 1996; 16: 360–366
   PubMed Web of Science ®Google Scholar
• Montaner J, Alvarez-Sabin J, Molina C, et al. Matrix met allopro-teinase expression after human cardioembolic strokes: Temporal profile and relation to neurological impairment. Stroke 2001; 32: 1759–1766
   PubMed Web of Science ®Google Scholar
• Sumii T, Lo EH. Involvement of matrix met alloproteinase in thrombolysis-associated hemorrhagic transformation after embolic focal ischemia in rats. Stroke 2002; 33: 831–836
   PubMed Web of Science ®Google Scholar
• Heo JH, Lucero J, Abumiya T, et al. Matrix met alloproteinases increases very early during experimental focal cerebral ischemia. I Cereb Blood Flow Metab 1999; 19: 624–633
   PubMed Web of Science ®Google Scholar
• Fujimura M, Gasche Y, Morita-Fujimura Y, et al. Early appearance of activated matrix met alloproteinase-9 and blood—brain barrier disruption in mice after focal cerebral ischemia and reperfusion. Brain Res 1999; 842: 92–100
   PubMed Web of Science ®Google Scholar
• Nagai N, Urano T, Endo A, et al. Neuronal degeneration and a decrease in laminin-like immunoreactivity is associated with elevated tissue-type plasminogen activator in the rat hippocampus after kainic acid injection. Neurosci Res 1999; 33: 147–154
   PubMed Web of Science ®Google Scholar
• Mignatti P, Rifkin DB. Plasminogen activators and matrix met alloproteinases in angiogenesis. Enzyme Protein 1996; 49: 117–137
   PubMedGoogle Scholar
• Okada Y, Copeland BR, Fitridge R, et al. Fibrin contributes to microvascular obstructions and parenchymal changes during early focal cerebral ischemia and reperfusion. Stroke 1994; 25: 1847–1854
   PubMed Web of Science ®Google Scholar
• Wang YC, Lin CW, Shen CC, et al. Tissue plasminogen activator for the treatment of intraventricular hematoma: The dose-effect relationship. I Neurol Sci 2002; 202: 35–41
   PubMed Web of Science ®Google Scholar
• Benchenane K, Berezowski V, Fernández-Monreal M, et al. Oxygen glucose deprivation switches the transport of tPA across the blood—brain barrier from an LRP-dependent to an increased LRP-independent process. Stroke 2005; 36: 1059–1064
   PubMed Web of Science ®Google Scholar
• Liao SL, Chen WY, Raung SL, et al. Association of immune responses and ischemic brain infarction in rat. Neuroreport 2001; 12: 1943–1947
   PubMed Web of Science ®Google Scholar
• Milner R, Campbell IL. Cytokines regulate microglial adhesion to laminin and astrocyte extracellular matrix via protein kinase C-dependent activation of the alpha6beta1 integrin. I Neurosci 2002; 22: 1562–1572
   Google Scholar
• Rubin LL, Hall DE, Porter S, et al. A cell culture model of the blood—brain barrier.] Cell Biol 1991; 115: 1725–1735
   PubMed Web of Science ®Google Scholar